Lunit

Lunit Days Payable Outstanding

The Days Payable Outstanding (DPO) of Lunit (328130.KQ) as of Nov 6, 2026 is 28.31. In the previous year, Days Payable Outstanding (DPO) was 43.39 — a change of -34.74% (lower).

Days Payable Outstanding

28.31

YoY

-34.74%

Last updated:

Days Payable Outstanding (DPO) of Lunit is 2024 28.31 . Days Payable Outstanding (DPO) of Lunit was 2023 43.39 . It decreases by -34.74% lower compared to the previous year.

The Lunit Days Payable Outstanding history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Days Payable Outstanding
Date
Days Payable Outstanding
Jan 1, 2020
281.17 KRW
Jan 1, 2021
82.86 KRW
Jan 1, 2022
32.42 KRW
Jan 1, 2023
43.39 KRW
Jan 1, 2024
28.31 KRW
The Lunit Days Payable Outstanding history
YEARDays Payable OutstandingYoY
28.31-34.74%
43.39+33.83%
32.42-60.87%
82.86-70.53%
281.17—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Lunit Stock analysis

What does Lunit do? Lunit Inc is a South Korean company headquartered in Seoul, operating within the Health Care sector. The company has 293 employees and went public on July 21, 2022, with its ticker listed as 328130.KQ and ISIN KR7328130000. Lunit provides software solutions for medical diagnostic imaging services, focusing on the development and supply of AI-powered medical software. Its offerings include cancer diagnostic aid solutions, cancer early detection solutions, and cancer risk prediction solutions. The company's technology leverages artificial intelligence to enhance diagnostic capabilities in healthcare settings. Lunit's website is www.lunit.io, where further information about its services and solutions can be accessed. The company operates in the Health Care industry, specifically targeting medical imaging and AI-driven diagnostic tools. As of the latest available data, Lunit is engaged in the development and commercialization of AI-based medical software, aiming to improve the accuracy and efficiency of cancer-related diagnostics. The firm's IPO date marks its transition to a publicly traded company, reflecting its growth and market position in the healthcare technology space. Lunit's focus on AI applications in medical imaging positions it as a key player in the digital health sector, particularly within the Korean market and beyond. The company's solutions are designed to support healthcare professionals in making more informed diagnostic decisions, potentially reducing the time and resources required for cancer detection and treatment planning. Lunit is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Lunit stock

Days Payable Outstanding (DPO) of Lunit is 28.31 in 2024.

Days Payable Outstanding (DPO) of Lunit changed from 43.39 to 28.31, representing a -34.74% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Days Payable Outstanding (DPO) Lunit since 2006 – with annual values, charts, and detailed analysis.

DPO measures the average number of days a company takes to pay its suppliers. Higher DPO can improve cash flow but may strain supplier relationships.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Days Payable Outstanding (DPO)'s Lunit with sector peers and the industry average to assess whether it is attractive.

To evaluate Days Payable Outstanding (DPO)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Days Payable Outstanding (DPO).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Lunit

All Key Metrics — Lunit